Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Cell Aging Research and FOXO4-DRI Peptide - Biotech Peptides

Cell Aging Research and FOXO4-DRI Peptide by Dr. Usman | Mar 4, 2022 | Research What is FOXO4-DRI? FOXO4-DRI, also known as Proxofim is a synthetic peptide developed by Dutch research teams. It contains a specific peptide antagonist named FOXO4-DRI. It is a mo

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Cell Aging Research and FOXO4-DRI Peptide

by Dr. Usman | Mar 4, 2022 | Research

What is FOXO4-DRI?

FOXO4-DRI, also known as Proxofim is a synthetic peptide developed by Dutch research teams. It contains a specific peptide antagonist named FOXO4-DRI. It is a modified protein type designed to trigger the selective death of aged cells. The discovery of this peptide analog has accentuated the attempts for cell aging reversal. Data suggests promising results during its initial testing in mice. FOXO4-DRI peptide bears the potential to promote cell longevity, possibly reduce physiological impacts linked to the onset of dementia, and suppress tumor development.

How does it work?

Cellular biologists have suggested that cells exhaust after 70 divisions and can no longer produce new cells. There does not appear to be any way to induce the continual division of cells without decay. Eliminating aged cells may make space for younger cell development, in a process called autophagy. Damaged cells tend to spread the decay process as well. Aged, decayed cells are considered to be suitable for nothing as they produce no energy. In addition, they keep occupying space within and between cells, hindering the growth of surrounding cells.

FOXO4-DRI peptide appears to work by removing these senescent cells that have outlived their efficacy. Considered to be the most effective senolytic agent to date; the peptide may potentially cease the communication of cells with p53 genes and convey signals that the cell is damaged and needs to be cleared by autophagy. Stem cells are considered to produce new cells after the death and clearance of aged cells. An increase in new cells to replace the aged ones may culminate in better overall physiological functioning.

Research Implications from FOXO4-DRI

Anti-Aging Impacts on Cells

Mitochondria is known as the ‘powerhouse of the cell’ as it is considered to primarily produce energy. The energy currency of an organism is called Adenosine Triphosphate (ATP). The organisms produce it inside the mitochondria due to several complex reactions. Lysosomes are responsible for removing cellular debris, and work as a dustbin of cells to remove aged and dead cells. If any of these structures becomes compromised, physiological functions are considered to decline. Studies found that test mice became healthier as compared to the control group. Mice in the test group achieved better energy levels, biomarkers for physiological function such as replenishment of follicle development, improved kidney function, and cell cycling with this protein.

Diabetes Research

FOXO proteins are considered to regulate insulin signaling and insulin-like growth factors (IGF). FOXO proteins may control cell growth, metabolism, and differentiation by acting on IGF. Future research may explore the effects of FOXO proteins in insulin signaling. This action may have correlative impacts on diabetes and its related complications.

Dr. Usman

Dr. Usman (BSc, MBBS, MaRCP) completed his studies in medicine at the Royal College of Physicians, London. He is an avid researcher with more than 30 publications in internationally recognized peer-reviewed journals. Dr. Usman has worked as a researcher and a medical consultant for reputable pharmaceutical companies such as Johnson & Johnson and Sanofi.

Latest Post

BPC157: Molecular Characterization, Pleiotropic Signaling Mechanisms, and Preclinical Research

Copper Peptides: Molecular Characterization, Mechanistic Biology, and Emerging Research

Modified GRF 1-29 and GHRP-2 Peptide Blend: Receptor Pharmacology, Somatotroph Signaling, and Neuroendocrine Research

Fragment 176-191, Modified GRF 1-29, and Ipamorelin Blend: Adipose Metabolism, GH Axis Modulation, and Receptor Signaling Research

PNC-27: Structural Characterization, HDM-2-Dependent Membrane Targeting, and Selective Tumor Cell Necrosis

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

comparison

Biotech Peptides vs Amino Asylum

Amino Asylum คล้ายกับ Biotech Peptides ตรงที่พวกเขามีข้อมูลการทดสอบจำนวนมากและมีรีวิวเชิงบวก อย่างไรก็ตาม สายผลิตภัณฑ์ของพวกเขากว้างขวางกว่าแค่เปปไทด์ ซึ่งอาจทำให้พวกเขาไม่ใช่ซัพพลายเออร์ที…

Source: muscleandbrawn.com
comparison

PSPeptides vs Biotech Peptides: A Direct Comparison

The most useful way to evaluate biotech peptides alternatives is a direct, factor-by-factor comparison. The table below shows how PSPeptides stacks up against Biotech Peptides across the cr…

Source: pspeptides.com
Research context

Read sources and limitations before applying a claim.

Humanin and Cardiovascular Research

by Dr. Usman | Jan 6, 2022 | Research Mitochondria are considered to play complex roles in energy production, cellular signaling, and metabolism, serving as the cell’s powerhouse. Earlier assumptions about the control of mitochondria’s function, maintenance, and biogenesis by the nucleus may be reconsidered in light of newer studies suggesting that some mitochondria possess a genomic sequence, translating into proteins that may affect the genomic expression of the nucleus. Research on the genomic sequence of mitochondria suggests that the rRNA possesses Open Reading Frames (ORFs), transcribing into small peptides, including Humanin (HN), Small Humanin-Like Peptides 1-6 (SHLPs), and Mitochondrial ORF-encoded peptide (MOTS-c). These peptides appear to bind to specific receptors in and out of the cells, exerting various speculated biological effects. The detectable concentration of Humanin in the skeletal muscles, hypothalamus, and cortex of murine models declined progressively with advancing age. Humanin may potentially be a subsequent biomarker of age. Humanin is suggested to have diverse biological functions, including cytoprotective and metabolic roles. Cytoprotective roles may involve protection against oxidative stress and injury, anti-inflammatory responses, neuroprotection, and cardioprotection. Metabolic protection roles may involve metabolic hemostasis, ATP production, reduction in visceral fat, and glucose-stimulated insulin secretion. Myocardial fibrosis may appear either as an age-related physiological change or due to various pathological phenomena such as Myocardial Infarction and ischemic reperfusion injury, contributing to cardiac dysfunction. It is speculated to affect both systolic and diastolic function and eventually progress to heart failure. The number of fibroblast cells present in cardiac tissue may directly correlate with the age of the heart tissue. Considering its ratio to the cardiac striated cells present may indicate the extent of age-related degenerative change in the heart. These fibroblasts may lead to the secretion of extracellular matrix proteins such as collagen type 1 that favors fibrosis.

Source: biotechpeptides.com ↗

Research in Wrinkle Reduction and Vialox

by Dr. Usman | Sep 23, 2022 | Research Vialox peptide has been suggested to interfere with nerve and muscle signal transmission. Signals are transmitted in normal conditions after nerves release acetylcholine from their axons. Contraction may occur after acetylcholine transportation through the neuromuscular junction and binds to a receptor on the muscle. Vialox peptide may halt contraction by binding to the AChR.[2] Acetylcholine is prevented from binding due to this action, which may induce less binding and fewer muscle contractions. At the neuromuscular junction, sodium ion release is constrained due to acetylcholine binding to a muscle receptor. Depolarization occurs, which may cause electrical pulses to develop wrinkling and creasing via the muscle contraction. Vialox may inhibit this process by binding to AChR. Vialox peptide inhibits acetylcholine binding when it binds to AChR. Vialox peptide has been suggested to only affect peripheral AChRs and may not affect central neuronal receptors. Unlike the other nicotinic acetylcholine receptor antagonists. This process suggests that Vialox only acts on the neuromuscular junction. Vialox peptide may potentially reduce skin texture in research cases by up to 11% and relief by 8%, according to one study. Since wrinkle size and ease are considered to be inversely proportional, Vialox may potentially reduce wrinkle development by an average of 8%. Approximately 60% and 47% of the animal subjects were studied. Vialox (Pentapeptide-3V), composed of lysine, threonine, and serine, is considered to stimulate collagen production while tightening the skin by acting directly on the dermis. Vialox may potentially boost melanin production, a considered protectant against UV damage. Disclaimer: The products mentioned are not intended for human or animal consumption. Research chemicals are intended solely for laboratory experimentation and/or in-vitro testing. Bodily introduction of any sort is strictly prohibited by law. All purchases are limited to licensed researchers and/or qualified professionals. All information shared in this article is for educational purposes only.

Source: biotechpeptides.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →